Accretion Pha, a company in the Pharmaceuticals industry, reported revenue of ₹55 crore and net profit of ₹8.00 crore for the September 2026 quarter.
Accretion Pha. (NSE: ACCPL-ST) closed at ₹207.00 on 20 Nov 2026, up 149.7% over the past year. Its market capitalisation is ₹230 crore and it trades at 17.5 times earnings.
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.